373P The role of concomitant RAS and BRAF mutations in influencing clinical outcome during BRAF-targeted treatment for metastatic colorectal cancer.
Saved in:
| Title: | 373P The role of concomitant RAS and BRAF mutations in influencing clinical outcome during BRAF-targeted treatment for metastatic colorectal cancer. |
|---|---|
| Authors: | Pretta, A.1 (AUTHOR), Ziranu, P.1 (AUTHOR), Spanu, D.1 (AUTHOR), Lai, E.1 (AUTHOR), Dettori, M.2 (AUTHOR), Manai, C.3 (AUTHOR), Balconi, F.1 (AUTHOR), Intini, R.4 (AUTHOR), S. Murgia1 (AUTHOR), Leone, A.G.5 (AUTHOR), Pozzari, M.1 (AUTHOR), Rasola, C.6 (AUTHOR), Bardanzellu, F.1 (AUTHOR), Maddalena, G.7 (AUTHOR), Pusceddu, V.1 (AUTHOR), Puzzoni, M.1 (AUTHOR), Pietrantonio, F.5 (AUTHOR), Bergamo, F.4 (AUTHOR), Lonardi, S.7 (AUTHOR), Scartozzi, M.1 (AUTHOR) |
| Source: | Annals of Oncology. 2022 Supplement 7, Vol. 33, pS707-S707. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2022.07.511 |
